研究将糖尿病药物Ozempic与罕见的、有视力威胁的眼部疾病NAION联系起来。 Study links Ozempic, a diabetes drug, to doubled risk of rare, vision-threatening eye condition NAION.

一项研究证实诺沃·诺迪斯克的糖尿病药物Ozempic与一种稀有的眼病“NAION”的危险性增加有关联,这可能造成不可逆转的视力丧失。 A study confirms a link between Novo Nordisk's diabetes drug, Ozempic, and an increased risk of a rare eye condition called NAION, which can cause irreversible vision loss. 与使用其他糖尿病药物的糖尿病患者相比,使用Ozempic的糖尿病患者患肿瘤的几率比使用其他糖尿病药物的糖尿病患者高出两倍多。 Diabetes patients using Ozempic were more than twice as likely to develop NAION compared to those using other diabetes medications. 尽管NAION病例的总体比率较低,医生建议告知病人这种潜在风险。 Despite the low overall rate of NAION cases, doctors recommend informing patients about this potential risk.